微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 61.48% | -8.07% | -7.52% | 51/140 | 52.37% | 健帆生物 | 78.46% | 行业排名> |
| 2025-12-31 | 66.48% | -10.99% | -2.27% | 33/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 68.02% | -10.91% | 0.46% | 30/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 67.71% | -12.28% | 1.24% | 30/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 66.88% | -13.99% | -10.46% | 30/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 74.69% | -0.89% | -2.17% | 12/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 76.35% | 1.35% | -1.08% | 13/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 77.18% | 2.85% | -0.74% | 12/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 77.75% | 2.82% | 3.18% | 12/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 75.36% | 1.34% | 0.04% | 15/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 75.33% | 1.28% | 0.38% | 17/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 75.04% | 1.47% | -0.77% | 16/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 75.62% | 1.11% | 1.68% | 17/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 74.37% | -0.65% | -0.01% | 20/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 74.38% | -1.26% | 0.58% | 19/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 73.95% | -2.69% | -1.12% | 20/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 74.79% | -0.99% | -0.09% | 20/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 74.85% | 3.31% | -0.63% | 20/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 75.33% | 2% | -0.87% | 22/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 75.99% | 10.38% | 0.6% | 24/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 75.54% | 2% | 4.26% | 20/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 72.45% | -3.37% | 5.24% | 39/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-06-30 | 68.85% | 2% | -8.18% | 38/140 | 60.36% | 正海生物 | 92.23% | 行业排名> |
| 2019-12-31 | 74.98% | 2% | 2% | 25/140 | 56.96% | 正海生物 | 92.69% | 行业排名> |